HomeMy WebLinkAboutResolution - 2023-R0132 - Award Number 1 NU58DP007289-01-00 with DSHS and CDCResolution No. 2023-RO132
Item No. 6.23
March 7, 2023
RESOLUTION
BE IT RESOLVED BY THE CITY COUNCIL OF THE CITY OF LUBBOCK:
THAT the acts of the Mayor of the City of Lubbock in executing, on behalf of the City of
Lubbock, Award Number 1 NU58DP007289-01-00, "A collaborative approach to addressing
the social determinants of health in west Texas," by and between the City of Lubbock and the
United States Department of Health and Human Services acting by and through the Center for
Disease Control and Prevention, and all related documents are hereby ratified in full. Said
Award is attached hereto and incorporated in this resolution as if fully set forth herein and shall
be included in the minutes of the City Council.
Passed by the City Council on
TTEST:
IZV71t/ V
Courtney Paz, In erim ity Secretary
APPROVED AS TO CONTENT:
/l ✓ e
) a �IM-MA r
Bill Howe puty City Mana
APPROVED AS TO FO
Ryan 4Koke, Assistant City Attorney
March 7, 2023
Q�7�
TRAY" AYOR
RES.USDHHS-CDC Award No. 1 NU58DP007289-01-00
2.16.23
Resolution No. 2023-R0132
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
�.w
Recipient Information
1. Recipient Name
LUBBOCK, CITY OF
1314 Avenue K
Lubbock, TX 79401-4051
[No Phone Record]
2. Congressional District of Recipient
19
3. Payment System Identifier (ID)
1756000590AI
4. Employer Identification Number (EIN)
756000590
5. Data Universal Numbering System (DUNS)
058213893
6. Recipient's Unique Entity Identifier (UEI)
LXDNEKWRVKI6
7. Project Director or Principal Investigator
Madeline Geeslin
mmcclure;u mylubbock.us
8067753091
8. Authorized Official
Mr. Tray Payne
traypayne kmylubbock.us
806-775-2010
Federal Agency Information
CDC Office of Financial Resources
9. Awarding Agency Contact Information
Reginald Simpson
Grants Management Specialist
sgv8(q cdc.gov
678-475-4971
10.Program Official Contact Information
Antwuanette Daniel
Program Support Staff
nty3;ri cdc.gov
4046394740
30. Remarks
Notice of Award
Award# 1 NU58DP007289-01-00
FAIN# NU58DP007289
Federal Award Date: 09/09 2022
Federal Award Information
11. Award Number
1 NU58DP007289-01-00
12. Unique Federal Award Identification Number (FAIN)
NU58DP007289
13. Statutory Authority
Public Health Service Act, as amended, Section 301(a) and Section 317K, 42 U.S.C. 241(a); 42 U.S.C. 247b-
12
14. Federal Award Project Title
A collaborative approach to addressing the social determinants of health in west Texas
15. Assistance Listing Number
93.945
16. Assistance Listing Program Title
Assistance Programs for Chronic Disease Prevention and Control
17. Award Action Type
New
18. Is the Award R&D?
No
Summary Federal Award Financial Information
19. Budget Period Start Date 09 30 2022 - End Date 09 29 2023
20. Total Amount of Federal Funds Obligated by this Action
$125,000.00
20a. Direct Cost Amount
$125,000.00
20b. Indirect Cost Amount
$0.00
21. Authorized Carryover
$0.00
22. Offset
$0.00
23. Total Amount of Federal Funds Obligated this budget period
$0.00
24. Total Approved Cost Sharing or Matching, where applicable
$0.00
25. Total Federal and Non -Federal Approved this Budget Period
$125,000.00
26. Period of Perfomance Start Date 09`30/2022 - End Date 09/29 2027
27. Total Amount of the Federal Award including Approved
Cost Sharing or Matching this Period of Performance
$125,000.00
28. Authorized Treatment of Program Income
ADDITIONAL COSTS
29. Grants Management Officer - Signature
Ms. Pamela Render
Grants Management Officer
Page 1
SO DEPARTMENT OF HEALTH AND HUMAN SERVICES
g Centers for Disease Control and Prevention
JA"
�4 q
Recipient Information
Recipient Name
LUBBOCK, CITY OF
1314 Avenue K
Lubbock, TX 79401-4051
[No Phone Record]
Congressional District of Recipient
19
Payment Account Number and Type
1756000590A 1
Employer Identification Number (EIN) Data
756000590
Universal Numbering System (DUNS)
058213893
Recipient's Unique Entity Identifier (UEI)
LXDNEKWRVKJ6
31. Assistance Type
Project Grant
32. Type of Award
Other
1 34. Accounting Classification Codes
Notice of Award
Award# 1 NU58DP007289-01-00
FAIN# NU58DP007289
Federal Award Date: 09/09/2022
33. Approved Budget
(Excludes Direct Assistance)
I. Financial Assistance from the Federal Awarding Agency Only
II. Total project costs including grant funds and all other financial participation
a. Salaries and Wages
$30,000.00
b. Fringe Benefits
$0.00
c. Total PersonnelCosts
$30,000.00
d. Equipment
$0.00
e. Supplies
$10,000.00
E Travel
$17,000.00
g. Construction
$0.00
h. Other
$18,000.00
i. Contractual
$50,000.00
j. TOTAL DIRECT COSTS
$125,0001—
IL INDIRECT COSTS
$0.00
1. TOTAL APPROVED BUDGET
$125,000.00
m. Federal Share $125,000 00
n. Non -Federal Share $0.00
FY-ACCOUNT NO. DOCUMENT NO. ADMINISTRATIVE CODE OBJECT CLASS CFDA NO. AMT ACTION FINANCIAL ASSISTANCE IAPPROPRIATION
2-9390JWG 22NU58DP007289 DP 41.51 93.945 S125,000.00 75-22-0948
Page 2
f� DEPARTMENT OF HEALTH AND HUMAN SERVICES Notice of Award
`+ Centers for Disease Control and Prevention Award# 1 NU58DP007289-01-00
r1°� ti FAIN# NU58DP007289
Federal Award Date: 09/09/2022
Direct Assistance
BUDGET CATEGORIES
PREVIOUS AMOUNT (A)
AMOUNT THIS ACTION (S)
TOTAL (A + B)
Personnel
$0.00
$0.00
Fringe Benefits$0.00
$0.00
—$0.00
$0.00
Travel
$0.00
$0.00
$0.00
Equipment
$0.00
$0.00
$0.00
Supplies
$0.00
$0.00
$0.00
Contractual
$0.00
$0.00
$0.00
Construction
$0.00
$0.00
$0.00
Other
$0.00
$0.00
$0.00
Total
$0.00
$0.00
$0.00
Page 3
AWARD ATTACHMENTS
LUBBOCK, CITY OF
1. Year 01 Terms and Conditions
1 NU58DP007289-01-00
10Office C() of Financial Resources
FR Office of Grants Services (OGS)
AWARD INFORMATION
Services. Support. Solutions.
Incorporation: In addition to the federal laws, regulations, policies, and CDC General Terms
and Conditions for Non -research awards at https://www.cdc.gov/grants/federal-repulations-
policies/index.html, the Centers for Disease Control and Prevention (CDC) hereby incorporates
Notice of Funding Opportunity (NOFO) number CDC-RFA-DP22-2210, entitled Closing the Gap
with Social Determinant of Health Accelerarators Plans, and application dated July 8, 2022,
as may be amended, which are hereby made a part of this Non -research award, hereinafter
referred to as the Notice of Award (NoA).
Approved Funding: Funding in the amount of $125,000 is approved for the Year 01 budget
period, which is September 30, 2022 through September 29, 2023. All future year funding will
be based on satisfactory programmatic progress and the availability of funds.
The federal award amount is subject to adjustment based on total allowable costs incurred
and/or the value of any third party in -kind contribution when applicable.
Note: Refer to the Payment Information section for Payment Management System (PMS)
subaccount information.
Financial Assistance Mechanism: Grant
Budget Revision Requirement: By October 31, 2022, the recipient must submit a revised
budget with a narrative justification. Please use the link below for the level of detail that is
required for your budget revision:https://www.cdc.gov/grants/documents/budget-r)reparation-
guidance.pdf
Failure to submit the required information in a timely manner may adversely affect the future
funding of this project. If the information cannot be provided by the due date, you are required
to contact the GMS/GMO identified in the CDC Staff Contacts section of this notice before the
due date.
FUNDING RESTRICTIONS AND LIMITATIONS
Notice of Funding Opportunity (NOFO) Restrictions: Restrictions that must be considered
while planning the programs and writing the budget are:
• Recipients may not use funds for research.
• Recipients may not use funds for clinical care except as allowed by law.
• Recipients may use funds only for reasonable program purposes, including personnel,
travel, supplies, and services.
• Generally, recipients may not use funds to purchase furniture or equipment. Any such
proposed spending must be clearly identified in the budget.
• Reimbursement of pre -award costs generally is not allowed, unless the CDC provides
written approval to the recipient.
• Other than for normal and recognized executive -legislative relationships, no funds may
be used for:
o publicity or propaganda purposes, for the preparation, distribution, or use of any
material designed to support or defeat the enactment of legislation before any
legislative body
o the salary or expenses of any grant or contract recipient, or agent acting for
such recipient, related to any activity designed to influence the enactment of
legislation, appropriations, regulation, administrative action, or Executive order
proposed or pending before any legislative body
See Additional Requirement (AR) 12 for detailed guidance on this prohibition and
additional guidance on lobbying for CDC recipients.
The direct and primary recipient in a cooperative agreement program must perform a
substantial role in carrying out project outcomes and not merely serve as a conduit for
an award to another party or provider who is ineligible.
Indirect Costs: Indirect Costs are not requested as a provision of this award
REPORTING REQUIREMENTS
Required Disclosures for Federal Awardee Performance and Integrity Information System
(FAPIIS): Consistent with 45 CFR 75.113, applicants and recipients must disclose in a timely
manner, in writing to the CDC, with a copy to the HHS Office of Inspector General (OIG), all
information related to violations of federal criminal law involving fraud, bribery, or gratuity
violations potentially affecting the federal award. Subrecipients must disclose, in a timely
manner in writing to the prime recipient (pass through entity) and the HHS OIG, all information
related to violations of federal criminal law involving fraud, bribery, or gratuity violations
potentially affecting the federal award. Disclosures must be sent in writing to the CDC and to
the HHS OIG at the following addresses:
CDC, Office of Grants Services
Pamela Render, Grants Management Officer
Centers for Disease Control and Prevention
Branch 5 Supporting Chronic Diseases and Injury Prevention
Email: p1r3(@cdc.gov (Include "Mandatory Grant Disclosures" in subject line)
UO-31
U.S. Department of Health and Human Services
Office of the Inspector General
ATTN: Mandatory Grant Disclosures, Intake Coordinator
330 Independence Avenue, SW
Cohen Building, Room 5527
Washington, DC 20201
Fax: (202)-205-0604 (Include "Mandatory Grant Disclosures" in subject line) or
Email: MandatoryGranteeDisclosures(&oig.hhs.gov
Recipients must include this mandatory disclosure requirement in all subawards and contracts
under this award.
Failure to make required disclosures can result in any of the remedies described in 45 CFR
75.371. Remedies for noncompliance, including suspension or debarment (See 2 CFR parts
180 and 376, and 31 U.S.C. 3321).
Last Updated September 2021, Page 2 of 3
CDC is required to report any termination of a federal award prior to the end of the period of
performance due to material failure to comply with the terms and conditions of this award in the
OMB -designated integrity and performance system accessible through SAM (currently FARIS).
(45 CFR 75.372(b)) CDC must also notify the recipient if the federal award is terminated for
failure to comply with the federal statutes, regulations, or terms and conditions of the federal
award. (45 CFR 75.373(b))
PAYMENT INFORMATION
The HHS Office of the Inspector General (OIG) maintains a toll -free number (1-800-HHS-TIPS [1-
800-447-8477]) for receiving information concerning fraud, waste, or abuse under grants and
cooperative agreements. Information also may be submitted by a -mail to hhstipse-oig.hhs.gov or
by mail to Office of the Inspector General, Department of Health and Human Services, Attn:
HOTLINE, 330 Independence Ave., SW, Washington DC 20201. Such reports are treated as
sensitive material and submitters may decline to give their names if they choose to remain
anonymous.
Payment Management System Subaccount: Funds awarded in support of approved activities
have been obligated in a subaccount in the PMS, herein identified as the "P Account'. Funds
must be used in support of approved activities in the NOFO and the approved application.
The grant document number identified beginning on the bottom of Page 2 of the Notice of Award
must be known in order to draw down funds.
Last Updated September 2021, Page 3 of 3